logo
Susan Collins votes 'no' as Senate approves Trump budget bill

Susan Collins votes 'no' as Senate approves Trump budget bill

Yahoo01-07-2025
Jul. 1—Sen. Susan Collins on Tuesday voted against President Donald Trump's marquis budget bill that would cut $1 trillion in health care and food assistance while strengthening border security and extending tax cuts that disproportionately benefit wealthy Americans.
Collins was one of three Republicans to vote against the bill, which included a $5 trillion increase to the debt limit. But her opposition was not enough to stop the bill. It led to a 50-50 tie, which was broken by Vice President JD Vance.
Collins' support for the bill was in doubt Tuesday morning after the Senate voted against her amendment to increase taxes on the ultra-wealthy and build up an emergency fund for rural hospitals expected to lose billions of dollars in Medicaid funding.
Prior to the final vote, Collins told reporters in Washington, D.C. that she continues to have "serious reservations" about the bill. They include proposed cuts to Medicaid, which provides insurance for about 400,000 Maine residents, or one out of over four Mainers.
"I truly don't know what's going to happen," Collins said Tuesday. "I have some serious reservations about the bill. I'm going to wait until we're done (to) know what direct direction we're going in before announcing my decision."
Collins, who is the only New England Republican in Congress, is up for reelection next year. And Democrats have already pounced on her decision to vote in support of advancing the bill over the weekend, despite concerns that it could force rural hospitals to reduce services or close altogether.
Trump's so-called "One Big Beautiful Bill Act" seeks to extend his 2017 tax cuts, which predominantly benefited the wealthy and are set to expire at the end of the year, while increasing spending on national and border security and slashing safety net programs. The bill would cut about $1 trillion from Medicaid and food assistance and is expected to add more than $3 trillion to the national debt.
Collins voted over the weekend to advance the bill, helping it clear the a key procedural hurdle by a 51-49 vote, but she has not committed to supporting it. Her vote is among those being closely watched in the Senate.
Republicans hold 53 seats and can only afford to lose one more vote and still send the bill back to the House for additional consideration. Sens. Rand Paul of Kentucky and Thom Tillis of North Carolina have already come out against the bill. Tillis announced he would not seek reelection.
Collins made her case on the Senate floor late Monday during a so-called vote-a-rama, where Democrats forced votes on a series of amendments, including several efforts to eliminate cuts to Medicaid, which is estimated to cause 11.8 million to lose their health insurance, including 60,000 Mainers.
Collins said her amendment would have doubled the $25 billion included in the bill to help rural hospitals cope with the cut in Medicaid and expand the list of eligible providers to include community health centers, nursing homes, ambulance services, skilled nursing facilities and others. The increase would have been funded by allowing Trump's tax cuts to expire on the wealthiest Americans — families earning more than $50 million and individuals earning more than $25 million.
"Rural providers — especially rural hospitals and nursing homes — are under great financial strain right now, with many having recently closed and others at risk of closing," Collins said. "When these facilities shut their doors, the people they serve are often left without access to health care. This amendment would help keep them open and caring for those who live in these rural communities."
The Senate rejected the amendment by a 78-22 vote shortly after midnight. It was supported by 18 Republicans, including Republican Sen. Lisa Murkowski of Alaska. U.S. Sen. Angus King, a Maine independent who caucuses with the Democrats, also supported the amendment.
Murkowski is also being closely watched and is under intense pressure from Senate leadership, who have tried to sweeten the deal by providing additional concessions for her home state, including exempting Alaska from having to pay a greater share of benefits provided under the Supplemental Nutrition Assistance Program.
Collins and Murkowski were the only Republicans to support an amendment from Democratic Sen. Patty Murray of Washington that sought to eliminate a provision that would prohibit Planned Parenthood from receiving Medicaid funding for health care services provided to low-income women. The amendment failed, 51-49.
King, meanwhile, has firmly opposed the bill, saying during a press conference last week that it was "the worst, most regressive and most harmful piece of legislation I have ever seen," and that he had "no choice whatsoever but to vote 'no' on this bill."
He reiterated his opposition in a floor speech over the weekend. He called on the Senate to kill the bill and draft a new one that maintains tax breaks for working families, while allowing those breaks to expire for people earning more than $400,000, which would eliminate the need for cuts to the safety net, including food assistance.
King said the bill could lead to the closures of up to five hospitals in Maine.
"All this damage to give a tax break to guys making a million bucks," King said. "It is a shame. And it's embarrassing to even be debating this bill."
Republicans are hoping to meet a self-imposed deadline of sending the bill to Trump's desk by Friday.
If approved, the budget would have to go back to the House, which passed its own version of the bill on June 22, with both Rep. Jared Golden, D-2nd District, and Rep. Chellie Pingree, D-1st District, opposed.
This story will be updated.
Copy the Story Link
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tips to help manage your buy now, pay later loans
Tips to help manage your buy now, pay later loans

Yahoo

timea few seconds ago

  • Yahoo

Tips to help manage your buy now, pay later loans

NEW YORK (AP) — Between rising prices and dwindling job growth, using 'buy now, pay later' on everything from concert tickets to fast food deliveries is becoming increasingly appealing. But greater use could also mean greater trouble, as more people fall behind on repaying these loans. Buy now, pay later loans gained popularity during the pandemic, especially among young people. While these loans can help you make large purchases without paying interest or undergoing a hard inquiry in your credit report, they can also easily be overused. About 4 in 10 Americans under the age of 45 say they've used "buy now, pay later″ services when spending on entertainment or restaurant meals, or when paying for essentials like groceries or medical care, according to a poll from The Associated Press-NORC Center for Public Affairs Research. Buy now, pay later loans were not previously reported to the three major credit reporting bureaus. But consumers will soon see the impact of buy now, pay later loans on their FICO credit scores. Whether you're a first-time or recurring user of buy now, pay later plans, here are some expert recommendations to use this tool responsibly. Focus on needs vs. wants Buy now, pay later plans divide purchases in monthly installments, typically in four payments. These loans are marketed as having low or no interest. Klarna, Afterpay, PayPal Later and Affirm are among the most popular buy now, pay later companies. These loans should ideally be used for large purchases or necessities, said Lauren Bringle, Accredited Financial Counselor at Self Financial. Bringle recommends asking yourself these questions before purchasing: Can I survive without this purchase right now? Do I need it for work, school, or a basic household need? Buy now, pay later is best used when you have a plan for the purchase, not for impulse buys. For example, when you need to buy a computer for school or a new refrigerator for your house, recommended Tyler Horn, head of planning at Origin, a budgeting app. Pause before purchasing Before deciding to take out a buy now, pay later loan, it's a good idea to pause and consider if it's the best financial decision for you, recommended Erika Rasure, Chief Financial Wellness advisor for Beyond Finance. Buy now, pay later plans can be positive budgeting tools when used strategically. However, it's essential you know your spending behaviors before using them, said Rasure. If you're an emotional spender, it might be hard for you to moderate your use of this tool and you could end up adding to your financial stress. 'Buy now, pay later can become a coping mechanism rather than a financial tool that can get you a good deal or improve your cash flow,' said Rasure. If you have other payments due, such as credit card or student loan payments, consider how a buy now, pay later loan will add to your monthly payments, recommended Sarah Rathner, Senior Writer for NerdWallet. Read the fine print Like credit cards, each buy now, pay later loan has terms and conditions that can vary by purchase and providers. It's crucial that you know what you're agreeing to before you sign up, recommended Michael Savino, Chief Lending Officer at Municipal Credit Union. 'Always read the fine print. Understand fees, repayment schedules, and what happens if you miss a payment or go into default,' said Savino. In general, if you miss a buy now, pay later payment, you can face fees, interest, or the possibility of being banned from using the services in the future. Avoid stacking BNPL loans You can easily run into difficulty keeping up with the cost and schedule of your repayments if you're trying to simultaneously pay off two, three or more loans, Savino said. 'Juggling multiple plans creates a blind spot and overall debt load, and multiple repayment dates are hard to manage,' Savino said. "So more loans makes it more difficult to budget.' The best approach: Stay mindful of your overall spending, and limit the number of buy now, pay later loans. Keep track of your loan(s) Whether or not you're paying for multiple buy now, pay later purchases at once, you want to be aware of where your money is going at any given time, recommended Courtney Alev, consumer advocate at Credit Karma. 'Buy now, pay later often requires automatic payments, so you want to make sure that your account is funded so that those payments are processing successfully,' recommended Jennifer Seitz, director of education at Greenlight, a financial literacy app for families. There are many ways to track your loan payments — from setting a reminder on your calendar, to creating an intricate excel spreadsheet or tracking them on an app, said Jesse Mecham, founder of the budgeting app YNAB. Finding the best method that works for you will help you stay on track and avoid late fees. Make buy now, pay later work for you For shoppers with low credit scores or no credit history, buy now, pay later loans can seem like the best, if not the only, loan option. If used moderately and responsibly, these short-term loans can be a positive lending exercise, said Savino. 'It allows you to to establish a baseline (and) get access to other affordable credit options that you can leverage that will ultimately provide financial wellness,' he added. Still, NerdWallet's Rathner emphasized that shoppers using these tools always remember that buy now, pay later is a form of borrowing money. 'It just kind of feels like you're given a little extra time to pay back," Rathner said. "But the reality is, if you miss payments, it can hurt your credit, much like missing payments with any other loan.' —— The Associated Press receives support from Charles Schwab Foundation for educational and explanatory reporting to improve financial literacy. The independent foundation is separate from Charles Schwab and Co. Inc. The AP is solely responsible for its journalism. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing
Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing

Yahoo

timea few seconds ago

  • Yahoo

Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing

Pfizer (PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the COVID-19 pandemic when the two were in regular contact to help speed up vaccine production. That relationship, he said, has created a direct line to discuss some of the headwinds the company faces out of Washington, D.C. In his second term, Trump is targeting the drug industry for high prices and overseas production — threatening tariffs as high as 250% on imported drugs. But Bourla told Yahoo Finance he believes Trump and other officials in D.C. are having productive conversations with industry leaders about tariffs and drug pricing. "I think [Trump] is educated, of course he doesn't go into the details, it's not his job, but he understands the dynamics [of the industry]," Bourla said. When asked about the tariff threat, Bourla shared his understanding from his ongoing discussions. "I don't want to speak for the president, but what he said today, which was very important also, was that it would be a very small tariff in the first couple of years. And then he opened the window for a grace period. Because I had this discussion with him and I had this discussion with multiple other members of the administration," Bourla said. Read more: What Trump's tariffs mean for the economy and your wallet The industry is awaiting the results of an investigation by the administration into how those tariffs will be implemented — and Bourla said the devil will be in the details. Currently, more than 90% of prescriptions in the US are from generics, which are often the cheapest drug type. Branded drugs are often the most expensive and are largely produced in the US. But some early components of the manufacturing process, key chemicals known as active pharmaceutical ingredients (APIs), are often made overseas in Europe or Asia. That will be important to understand when the final ruling for the tariffs is made. "We need to understand if the API will dictate the country of origin, or where the final product is made," Bourla said. Pfizer is also one of the companies that received a letter from Trump last week detailing demands to reduce prices for Medicare and Medicaid enrollees to match the lowest price paid by developing nations, known as Most Favored Nations (MFN). The company is currently planning for the implementation of reduced prices, as well as working on how to mitigate negative impacts, Bourla said. "We are still discussing it with the president. ... The devil could be in the details in these stages," he said. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

"Another Day Of Reality Eroding Before Our Eyes": People Can't Believe Donald Trump Actually Made This Claim About Lowering Drug Prices
"Another Day Of Reality Eroding Before Our Eyes": People Can't Believe Donald Trump Actually Made This Claim About Lowering Drug Prices

Yahoo

timea few seconds ago

  • Yahoo

"Another Day Of Reality Eroding Before Our Eyes": People Can't Believe Donald Trump Actually Made This Claim About Lowering Drug Prices

Donald Trump's math on cutting drug prices didn't add up. Again. The president this weekend repeated his promise to get pharma companies to lower the cost of medications for Americans, who often have to pay much more for certain drugs than people abroad. But the actual amount of the 'tremendous drop' in cost that Trump boasted about had critics scratching their heads. Related: 'You know, we've cut drug prices by 1,200, 1,300, 1,400, 1,500%,' Trump said. 'I don't mean 50%. I mean 14, 1,500%,' he added. But as many on social media pointed out, that would mean all drugs are free and people actually get paid to receive them. @Acyn / CNN / Via Also, drug prices haven't actually come down, despite Trump's pressure on pharmaceutical companies. Trump appeared to acknowledge that when he later said, 'We'll be dropping drug prices ... by 1,200, 1,300 and even 1,400% and 500% but not just 50% or 25%, which normally would be a lot because the rest of the world pays much less for the identical drug.' Related: Reality is 'eroding before our eyes,' said one critic. Others agreed. @JenniferEValent / CNN / Via @gtconway3d / CNN / Via @jjabbott / CNN / Via @greggnunziata / CNN / Via Related: @SedgeDienst / CNN / Via @AmoneyResists / CNN / Via @PWBaugh. CNN / Via @michaelpfreeman / Via @IsaacDovere / Via Related: @AuforGA / Via @WajahatAli / Via @svdate / Via This article originally appeared on HuffPost. Also in In the News: Also in In the News: Also in In the News:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store